Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer (Q46562452)

23 December 2017

http://europepmc.org/abstract/MED/25039982

title

Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer (English)

1 reference

23 December 2017

http://europepmc.org/abstract/MED/25039982

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Anna S Berghoff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Andreas von Deimling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Georg Widhalm

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Berthold Streubel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Johannes A Hainfellner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Karin Dieckmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Monika Hackl

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Christoph Zielinski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Peter Birner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Adelheid Wöhrer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

5 August 2014

1 reference

23 December 2017

http://europepmc.org/abstract/MED/25039982

published in

Histopathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

684-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

MET as a possible target for non-small-cell lung cancer

13 June 2020

cites work

1 reference

Targeting c-MET in the battle against advanced nonsmall-cell lung cancer

21 January 2018

1 reference

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer

21 January 2018

1 reference

Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.

21 January 2018

1 reference

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma

21 January 2018

1 reference

cMET and phospho-cMET protein levels in breast cancers and survival outcomes

21 January 2018

1 reference

Targeting the hepatocyte growth factor-cMET axis in cancer therapy

21 January 2018

1 reference

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

21 January 2018

1 reference

Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma

21 January 2018

1 reference

c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.

21 January 2018

1 reference

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer

21 January 2018

1 reference

Brain metastases: pathobiology and emerging targeted therapies.

21 January 2018

1 reference

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis

21 January 2018

1 reference

Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis

21 January 2018

1 reference

Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry

21 January 2018

1 reference

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

21 January 2018

1 reference

ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

21 January 2018

1 reference

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

21 January 2018

1 reference

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.

21 January 2018

1 reference

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

21 January 2018

1 reference

Adjusting for multiple testing--when and how?

21 January 2018

1 reference

Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology

21 January 2018

1 reference

Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer

21 January 2018

1 reference

Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells

21 January 2018

1 reference

Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039982%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference